Savara (SVRA) Exchange Rate Effect (2011 - 2026)
Savara (SVRA) reported Exchange Rate Effect of $74000.0 for Q1 2026, up 346.67% year-over-year from $16567.2 in Q1 2025, and up 305.56% on a QoQ basis from -$36000.0 in Q4 2025.
Savara (SVRA) has 12 years of Exchange Rate Effect data on file, last reported at $74000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 346.67% year-over-year to $74000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$173000.0 (down 367.57% YoY) and the FY2025 annual result came in at -$277000.0, down 5440.0% from the prior year.
- Exchange Rate Effect climbed to $74000.0 in Q1 2026 per SVRA's latest filing, from -$36000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $120000.0 in Q4 2022 and bottomed at -$145000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$30000.0 (2025), against an average of -$24470.6.
- The widest annual swing landed in 2025, when Exchange Rate Effect sank 1600.0%; it then surged 346.67% in 2026.
- Tracing SVRA's Exchange Rate Effect over 5 years: stood at $120000.0 in 2022, then sank by 73.33% to $32000.0 in 2023, then sank by 318.75% to -$70000.0 in 2024, then surged by 48.57% to -$36000.0 in 2025, then jumped by 305.56% to $74000.0 in 2026.
- Per Business Quant, the three latest SVRA Exchange Rate Effect figures stand at $74000.0 (Q1 2026), -$36000.0 (Q4 2025), and -$74000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | 74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Jun 30, 2025 | -137,000.00 |
| Jun 30, 2025 | -137,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Dec 31, 2022 | 120,000.00 |
| Dec 31, 2022 | 120,000.00 |
| Sep 30, 2022 | -145,000.00 |
| Sep 30, 2022 | -145,000.00 |
| Jun 30, 2022 | -41,000.00 |
| Jun 30, 2022 | -41,000.00 |
| Mar 31, 2022 | -24,000.00 |
| Mar 31, 2022 | -24,000.00 |
| Dec 31, 2021 | -62,000.00 |
| Dec 31, 2021 | -62,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -27,000.00 |
| Jun 30, 2021 | -27,000.00 |
| Mar 31, 2021 | -28,000.00 |
| Mar 31, 2021 | -28,000.00 |
| Dec 31, 2020 | 342,000.00 |
| Dec 31, 2020 | 342,000.00 |
| Sep 30, 2020 | -159,000.00 |
| Sep 30, 2020 | -159,000.00 |
| Jun 30, 2020 | -54,000.00 |
| Jun 30, 2020 | -54,000.00 |
| Mar 31, 2020 | 41,000.00 |
| Mar 31, 2020 | 41,000.00 |
| Dec 31, 2019 | -34,000.00 |
| Dec 31, 2019 | -34,000.00 |
| Sep 30, 2019 | 70,000.00 |
| Sep 30, 2019 | 70,000.00 |
| Jun 30, 2019 | -71,000.00 |
| Jun 30, 2019 | -71,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Dec 31, 2018 | -117,000.00 |
| Dec 31, 2018 | -117,000.00 |
| Sep 30, 2018 | 6,000.00 |
| Sep 30, 2018 | 6,000.00 |
| Jun 30, 2018 | -19,000.00 |
| Jun 30, 2018 | -19,000.00 |
| Mar 31, 2018 | 11,000.00 |
| Mar 31, 2018 | 11,000.00 |
| Dec 31, 2017 | 75,000.00 |
| Dec 31, 2017 | 75,000.00 |
| Sep 30, 2017 | -62,000.00 |
| Sep 30, 2017 | -62,000.00 |
| Jun 30, 2017 | 1,000.00 |
| Jun 30, 2017 | 1,000.00 |
| Mar 31, 2017 | -6,000.00 |
| Mar 31, 2017 | -6,000.00 |
| Dec 31, 2013 | -478.00 |
| Dec 31, 2013 | -478.00 |
| Sep 30, 2013 | -223.00 |
| Sep 30, 2013 | -223.00 |
| Jun 30, 2013 | 1,129.00 |
| Jun 30, 2013 | 1,129.00 |
| Mar 31, 2013 | -2,428.00 |
| Mar 31, 2013 | -2,428.00 |
| Dec 31, 2011 | 20,972.00 |
| Dec 31, 2011 | 20,972.00 |
| Sep 30, 2011 | -30,594.00 |
| Sep 30, 2011 | -30,594.00 |